AlzeCure Pharma AB's total assets for Q1 2025 were kr24.72M, a decrease of -28.22% from the previous quarter. DE:AC6 total liabilities were kr8.64M for the fiscal quarter, a 4.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.